A new drug often makes waves in the headlines and the stock market when it’s shown to improve relevant outcomes. Somehow it’s not quite as newsworthy when remission rates increase from 55% to 68% in kids with Crohn’s disease… if it happens simply by improved communication among doctors.

In short, we need to invest more in quality improvement and we need to invite all players—doctors, nurses, pharmacists, therapists, administrators, tech people, and especially patients—to join in on the investment.